Replay available

Teladoc Health, Inc. (TDOC) Q3 2025 Earnings Call

Teladoc Health, Inc. (NYSE: TDOC) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.

Wed, October 29, 2025 at 5:00 PMendedReplay
Teladoc Health, Inc. (TDOC) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Mike Minchak

Head of Investor Relations

Chuck DeVita

Chief Executive Officer

Mala Murthy

Chief Financial Officer

David Roman

Analyst at Goldman Sachs

Richard Close

Analyst at Canaccord Genuity

Lisa Gill

Analyst at JP Morgan

Jessica Tassin

Analyst at Piper Sandler

Jalinder Singh

Analyst at Perlis

Elizabeth Anderson

Analyst at Evercore

Sarah James

Analyst at Cantor

Charles Reeve

Analyst at Cowen

Replay transcript excerpt

Good afternoon. Thank you for attending today's Teladoc Health Second Quarter 2025 Earnings Call. My name is Victoria and I'll be your moderator today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you would like to ask a question, please press star followed by one on your telephone keypad. I would now like to pass the conference over to Mike Minchak, Head of Investor Relations for Teladoc Health. Thank you. You may proceed. Thank you and good afternoon. Today, after the market closed, we issued a press release announcing our second quarter 2025 financial results. This press release and the accompanying slide presentation are available in the investor relations section of the TeladocHealth.com website. On this call to discuss our results are Chuck DeVita, Chief Executive Officer, and Mala Murthy, Chief Financial Officer. During this call, we will also discuss our outlook and our prepared remarks will be followed by a question and answer session. Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating our performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliations thereof can be found in the press release that is posted on our website. Also, please note that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause our actual results to differ materially from those expressed or implied on this call. For additional information, please refer to our cautionary statement in...

More from Teladoc Health, Inc.